Stocks Health care ENTA
NASDAQ · Health careEnanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals Inc brought in $65.3M of revenue over the twelve months to June 30, 2026, up 0.7% from a year earlier. It posted a net loss of $63.2M. In fiscal 2025 capital spending exceeded operating cash flow by $32.2M. At June 30, 2026 it held $33.4M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 12, 2026.
What Enanta Pharmaceuticals Inc does
Enanta Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ENTA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $65.3M | -$81.9M | -$3.84 | -$32.2M |
| 2024 | $67.6M | -$116M | -$5.48 | -$96.7M |
| 2023 | $79.2M | -$133.8M | -$6.38 | -$112.2M |
| 2022 | $86.2M | -$121.8M | -$5.91 | -$86.9M |
| 2021 | $97.1M | -$79M | -$3.92 | -$70.7M |
| 2020 | $122.5M | -$36.2M | -$1.81 | $5.6M |
Latest SEC filings
What Enanta Pharmaceuticals Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Quarterly report 10-Q · period to June 30, 2026
- August 10, 2026
- July 2, 2026
- July 2, 2026
- June 23, 2026Other event 8-K
- June 18, 2026
- May 13, 2026
- May 13, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about ENTA
What does Enanta Pharmaceuticals Inc do?
Enanta Pharmaceuticals Inc is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker ENTA.
Is Enanta Pharmaceuticals Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $63.2M on revenue of $65.3M.
How much revenue does Enanta Pharmaceuticals Inc make?
Over the twelve months to June 30, 2026 Enanta Pharmaceuticals Inc reported revenue of $65.3M. That is 0.7% more than a year earlier.
When did Enanta Pharmaceuticals Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 12, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from August 14, 2026.
Similar companies
Follow ENTA
Get an email when Enanta Pharmaceuticals Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow ENTA: get an email when it filesWhere the numbers come from
Financial figures are the values Enanta Pharmaceuticals Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.